Roche Stories

Company Statement: Delhi High Court Interim Order, March 03, 2017

An Opportunity for India: Improving Transparency

Providing confidence and support to patients

Approval of biosimilars must be subject to rigorous clinical and regulatory standards.

Media Relations

Our aim is to provide news media with clear, accurate and timely information about our pharmaceutical products, services and business activities.

Media Release

Roche Pharma India partners with Cipla to create greater access to key medicines

Media Enquiries

For media enquiries, please contact:
Tel: +91 (22) 33941081
Email: shilpika.das@roche.com

Cell:- +91 98677 49149